Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intradermal hepatitis B virus immunization: immunogenicity and reactogenicity.

S Sirinavin1, T Muchacheap, K Khupulsup

  • 1Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

The Southeast Asian Journal of Tropical Medicine and Public Health
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays.

Journal of medical virology·2010
Same author

H1N1 2009 influenza among healthcare workers in a tertiary care hospital in Thailand.

The Journal of hospital infection·2010
Same author

NGSP and IFCC-derived NGSP HbA1c can be used interchangeably.

Diabetes research and clinical practice·2009
Same author

Influence of hemoglobin E on measurement of hemoglobin A1c by immunoassays.

Diabetes research and clinical practice·2008
Same author

Neonatal astrovirus gastroenteritis during an inborn nursery outbreak.

The Journal of hospital infection·2006
Same author

Systemic nontyphoidal Salmonella infection in normal infants in Thailand.

The Pediatric infectious disease journal·2001

Low-dose intradermal hepatitis B virus (HBV) vaccination in young adults elicits a strong serological response. This cost-effective intradermal HBV immunization strategy offers a viable alternative for mass immunization programs.

Area of Science:

  • Vaccinology
  • Immunology
  • Public Health

Background:

  • Mass immunization with the hepatitis B virus (HBV) vaccine is essential for adults.
  • High costs of conventional HBV vaccination hinder widespread accessibility.

Purpose of the Study:

  • To investigate the serological response and adverse reactions to low-dose intradermal HBV vaccination in young adults.
  • To evaluate the efficacy of 1 or 2 microgram intradermal doses of a yeast-derived HBV vaccine.

Main Methods:

  • A study involving 58 female volunteers (aged 20-33) seronegative for HBV.
  • Intradermal administration of 1 or 2 microgram HBV vaccine doses at 0, 1, and 6 months.
  • Anti-HBs antibody concentrations measured by enzyme-immunoassay at 1, 6, and 7 months.

Related Experiment Videos

Main Results:

  • High seroconversion rates at 7 months: 90% for the 1 microgram group and 96% for the 2 microgram group.
  • Both doses achieved anti-HBs concentrations >10 IU/L, indicating protective immunity.
  • Most common adverse reaction was a transient pigmented macule, which was not bothersome.

Conclusions:

  • Intradermal low-dose HBV vaccination is a safe and effective method for inducing protective immunity in young adults.
  • This approach presents a cost-effective alternative for mass HBV immunization strategies.
  • Intradermal HBV immunization could significantly improve vaccine accessibility for large populations.